Only 14% of promised COVID-19 vaccines have been delivered to impoverished countries
- The report presented by the People Vaccine’s Alliance, which brings together more than 70 international organizations, points out that 1.3% of the population of impoverished countries has received all the doses. The pharmaceutical and the most enriched countries have been found guilty of the accumulation of vaccines, according to the NGO.
The People Vaccine’s Alliance has released the A of Mergers reality report, which shows the status of the COVID-19 vaccine in the world. The coalition consists of organizations such as Oxfam, ActionAid or Amnesty International, among others. According to the report, the enriched countries committed to allocating 1.8 billion doses to the poorest countries, but only EUR 261 million has been reached. They hold the representatives of the G20 accountable, where nineteen countries account for 85% of the world’s wealth.
The coalition has denounced that the pandemic is dragging on longer than necessary because the availability of vaccines is not equal for all. The blame lies with pharmaceutical companies and rich countries. In fact, what they initially committed is nothing; the document clarifies that only one of the seven prescribed doses has been received.
The United Kingdom, which pledged $100 million, has given less than 10%. Canada promised to deliver 40 million doses, but has only given 8%. The United States is the country with the most vaccines (EUR 1.1 billion), although it accounts for only 16% of what it has agreed. The coalition also stresses that Covax has failed, an organization that works for an equitable distribution of vaccines. Political leaders have already said 994 million doses would be administered to Covax, but at the moment 120 million, or 12%, have been received.
I don't know who needs to hear it, but we can't rely on charity to vaccinate the world. @g20org leaders - here's to pay for reality:https://t.co/zsE1askfFp https://t.co/kCZhS9nuh9 pic.twitter.com/DZGkOKFbA0
— The People's Vaccine (@peoplesvaccine) October 23, 2021
Janssen farmazia multinazioanalak txertoaren ikerketa bertan behera uzteko erabakia hartu du, batzorde batek ondorioztatu ostean txertoak ez dituela giza immunoeskasiaren birusari aurre egiteko baldintzak betetzen.
Farmazia enpresa alemaniarrak hamar mila milioi euro irabazi ditu Covid-19aren aurkako txertoen patenteei esker. Hainbat ikerketak frogatu dute farmazeutiken lobbyek oztopatu dituztela patenteak askatzeko akordioak. BioNTechek sare sozialetako mezuak zentsuratu nahi izan ditu,... [+]
COVID-19 kasuek gora egin dute Europan eta 60 eta 79 urte artekoei eta gaitza larri pasatzeko arrisku handiagoa dutenei txertoaren laugarren dosia “berehala” jartzea gomendatu dute Sendagaien Europako Agentziak (EMA) eta Gaixotasunen Prebentziorako eta Kontrolerako... [+]
Erresuma Batuko Airfinity datu analizatzaileak aurreikusi du Europar Batasunak eta G7ko estatuek erositako milioika txerto dosi xahutuko direla erabili aurretik; ohartarazi dute banaketa arazoengatik izan litekeela. UNICEFek jakinarazi du herrialde pobretuek uko egin zietela 100... [+]
Nafarroako Osasun Publikoaren eta Lan Osasunaren Institutuaren azken txostenaren arabera, COVID-19ak eragindako heriotza kopurua oraingoaren bikoitza izango litzateke, haren kontrako txertoaren kanpaina martxan jarri ez balitz.
Many of the decisions of this pandemic need transparent, free and in-depth discussions. We should discuss infant vaccination against COVID-19, as the work on this Seminar on Innovation in Primary Care (SIAP) and the Spanish Network of Primary Care (REAP) have made clear.
The... [+]
Patenteetatik libre dagoen COVID-19aren aurkako txerto berri bat sortu du Texasko haurrentzako ospitaleko txertoen garapenerako zentroak (AEB). Indiak dagoeneko onartu du txerto hori erabiltzeko emergentziazko baimena eta haren sortzaileek espero dute laster Indonesian,... [+]
COVID-19ari dagokionez, abenduaren 22an hasi dute umeei zuzenduriko "hautuzko txertaketa" Ipar Euskal Herrian. Desadostasunak eta ulertu ezinak areagotzen ditu azken neurri honek.
Ayoade Alakija Afrikako Batasuneko presidentekideak salatu du omikron aldaera txertoen banaketa desorekatuaren ondorioz sortu dela. Bestalde, EMAk bosgarren txertoaren merkaturatzea onetsi du, “eraginkorra, kalitatezkoa eta segurua” dela baieztatuta; oraindik ez... [+]